Liposomes are small, artificial and lipid-based bilayered spherical vesicles, which are created spontaneously by hydrated phospholipids.

The global liposome manufacturing market size is estimated to reach USD 2.34 billion by 2035, growing at a CAGR of 9.7% during the forecast period.

Liposomes are artificial vesicles that carry the potential to be used as an effective drug…

Gene switches have garnered significant attention from drug developers owing to their ability to control the activity of genetically modified cell products in vivo

The global gene switch market size is estimated to grow from USD 795 million in 2025 to USD 2,478 million by 2035, representing a CAGR of 12.03% during the forecast period till 2035.

Gene switch developers are adopting various operational…